Li Huang

Li Huang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Pulmonary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SDSongyun Deng
Songyun Deng
LZLina Zhang
Lina Zhang
YMYunan Mo
Yunan Mo
YHYan Huang
Yan Huang
WLWenchao Li
Wenchao Li
YAYuhang Ai
Yuhang Ai

1 July 2021 in Life Sciences
Verified
Journal Article
Closed access
LZLina Zhang
Lina Zhang
YJYuan Jiang
Yuan Jiang
SDSongyun Deng
Songyun Deng
YMYunan Mo
Yunan Mo
YHYan Huang
Yan Huang
YAYuhang Ai
Yuhang Ai

1 May 2010 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
LHLi Huang
Li Huang
QYQidong Yang
Qidong Yang
LZLe Zhang
Le Zhang
XCXuan Chen
Xuan Chen
QHQing Huang
Qing Huang
HWHongxing Wang
Hongxing Wang

1 September 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LHLi Huang
Li Huang
LZLina Zhang
Lina Zhang
ZLZhiyong Liu
Zhiyong Liu
SZShuangpin Zhao
Shuangpin Zhao
DXDaomiao Xu
Daomiao Xu
YAYuhang Ai
Yuhang Ai

28 May 2020 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
LZLina Zhang
Lina Zhang
XPXiaobei Peng
Xiaobei Peng
YAYuhang Ai
Yuhang Ai
LLLi Li
Li Li
SZShuangpin Zhao
Shuangpin Zhao
LHLi Huang
Li Huang

26 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JHJiyun Hu
Jiyun Hu
MAMeilin Ai
Meilin Ai
SXShucai Xie
Shucai Xie
ZQZhaoxin Qian
Zhaoxin Qian
LZLina Zhang
Lina Zhang
LHLi Huang
Li Huang
Cardiac arrest (CA) is a serious health concern that often results in mortality or severe neurological dysfunction in the case of survival. Our aim was to explore the neurological prognostic factors in patients with CA. This retrospective observational study included adult patients with CA. We investigated serum neuron-specific enolase (NSE), S100 calcium-binding protein β (S100β), and indices and parameters at 1, 3, 5, 7 and intensive care unit (ICU) discharge days after CA. The primary study endpoint was the Cerebral Performance Category (CPC) scale score at ICU discharge, which was dichotomized as good neurological outcome (CPC 1–2: full recovery or moderate disability) and poor neurological outcome (CPC 3–5: severe disability, vegetative state, or death). Of the 191 adult patients with CA, 42 (22%) had good neurological outcomes, and 149 (78%) had poor neurological outcomes. NSE at 1,3,5,7 and ICU discharge days showed excellent predictive accuracy for neurological outcomes (area under the curve [AUC]: 0.666, 0.716, 0.870, 0.739, and 0.901, respectively). However, S100β exhibited general predictive power (AUC: 0.666, 0.573, 0.607, 0.594, 0.727). Finally, the early warning model, which combined day 1 NSE, day 1 S100β, cardiac arrest time, SOFA scores, APACHE II scores, and age, was used to screen CA patients with poor neurological prognosis at early stages and had an AUC of 0.792. Serum concentrations of NSE and S100β were significantly elevated in CA patients and could be prognostic biomarkers to predict neurological outcomes. Day 1 NSE and S100β combined with multiple indicators could be a decent early warning model for poor neurological prognosis in patients with CA.